---
granola_id: 3830a426-6837-4786-b9c0-af9caae2705e
title: "Samir Jain and Emre Karatas"
type: note
created: 2025-06-12T16:36:54.110Z
updated: 2025-06-12T17:01:40.155Z
attendees:
  - samirxjain@gmail.com
  - JAIN Samir
---
### Medidata’s Current Initiatives

- Collecting PII in clinical trials, storing it separately from EDC/Rave database with embedded tokenization engines
- Working with token vendors (Datavant, HealthVerity) to provide sponsors with tokenized patient data
- Developing MyChart integration for patient enrollment and record verification
- Building EHR to EDC capabilities focused on user-friendly data entry workflows in Rave
- Positioning Rave as the “friendliest EDC” for presenting EHR data in data entry workflows

### Market Landscape & Opportunities

- Shift in tokenization market due to Datavant-Ciox acquisition causing partners to seek alternatives
- Current challenges in clinical trial recruitment and prescreening processes
- ROI vendor partnerships needed for comprehensive record access
- Discussion of Paradigm’s market position and challenges in clinical trial innovation
- Barriers for startups in life sciences: difficulty getting sponsor attention despite low technology bar

### Emerging Technologies & Partnerships

- GemMab and OpenAI partnership developing beyond basic enterprise ChatGPT implementation
- Potential future evolution of EDC systems with AI integration
- Regulatory environment becoming more AI-friendly
- Discussion of potential disruption in EDC space likely to come from outside established players
- Possibility of trials running without traditional EDC systems in partnership with companies like Regeneron or GemMab

#### Next Steps

- Connect Integral team with Medidata for potential partnership
- Schedule follow-up meeting later in summer
- Coordinate in-person meeting if in New York

Chat with meeting transcript: https://notes.granola.ai/d/3830a426-6837-4786-b9c0-af9caae2705e
